Donor parity no longer a barrier for female-to-male hematopoietic stem cell transplantation

Halteren, Astrid G. S. van; Dierselhuis, Miranda P.; Netelenbos, Tanja; Fechter, Mirjam

doi:10.4161/chim.29562

Cited by 6 publications

(2 citation statements)

References 28 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…AW Loren et al have found that parity of the donor does not have an impact on the occurrence of acute GVHD and overall surv ival ; nevertheless, it increases the incidence of chronic GVHD ( 25 ). One of the challenging contradictions between our results and several previous findings is that they have mentioned that GVHD incidence in female to male transplantations was significantly greater than the reverse combination ( 26 - 28 ).…”

Section: Discussioncontrasting

confidence: 99%

Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience

Mehdizadeh

Parkhideh

Salari

et al. 2021

Med. J. Islam. Republ. Iran

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 99%

Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience

Mehdizadeh

Parkhideh

Salari

et al. 2021

Med. J. Islam. Republ. Iran

View full text Add to dashboard Cite

show abstract

“…With better insight, the rate of recurrent miscarriage in affected pregnant women might be reduced; low-risk female donor/male recipient pairs could be identified. It might then not only justify a female donor/male recipient HSCT in a young patient with advanced leukemia, it might also justify the transplantation early on in the disease course, even for less than high-risk leukemia [22]. Early and low risk transplantations can help to save lives and resources [23].…”

mentioning

confidence: 99%

HY: Foe or Maybe Friend?

Gratwohl

2015

Biology of Blood and Marrow Transplantation

View full text Add to dashboard Cite

In conclusion, recent years have witnessed acceptance of and development of diverse approaches to haploidentical transplantation. The original approach, transplantation of high numbers of T celledepleted hematopoietic progenitor cells and no post-transplantation immune suppression has, with over 15 years' follow-up, provided well-established outcomes in adults and children and continues to offer unique opportunities for innovative immunotherapeutic strategies. All the recent reports of unmanipulated haploidentical transplantation have fostered interest and debate in the field and, most importantly, served to substantially extend its use. The new 2-step approach, as adopted by Grosso et al. [1], provides very interesting results. It is to be hoped they will be confirmed in a longer follow-up and a larger cohort of patients.

show abstract